Latest AMTI reports update at 2023-11-09: 2023-Q32022-Q42022-Q3
Applied Molecular Transport logo
Applied Molecular Transport AMTI
$ 0.26 0.0%

Applied Molecular Transport Balance Sheet 2011-2024 | AMTI

Annual Balance Sheet Applied Molecular Transport

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-56.5 M -156 M - -12.7 M -20.3 M - - - - - - -

Long Term Debt

49 K 167 K - - - - - - - - - -

Long Term Debt Current

4.64 M 3.58 M - - - - - - - - - -

Total Non Current Liabilities

- - - 106 M 64.2 M - - - - - - -

Total Current Liabilities

15.1 M 14.3 M 7.66 M - - - - - - - - -

Total Liabilities

46.6 M 50.5 M 8.51 M 110 M 67.4 M - - - - - - -

Deferred Revenue

- - - - - - - - - - - -

Retained Earnings

-366 M -240 M -139 M -72.8 M -44.8 M - - - - - - -

Total Assets

107 M 214 M 140 M 38.5 M 23.2 M - - - - - - -

Cash and Cash Equivalents

61.1 M 160 M 5.95 M 12.8 M 20.3 M - - - - - - -

Book Value

60.8 M 164 M 132 M -71.7 M -44.1 M - - - - - - -

Total Shareholders Equity

60.8 M 164 M 132 M -71.7 M -44.1 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Applied Molecular Transport

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 114 K 49 K 59 K - 190 K 167 K 221 K 282 K 344 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

3.78 M 4.31 M 47.2 M 46.6 M 46.2 M - 53.8 M 50.5 M 19.5 M 16.2 M 12.8 M 8.51 M 8.51 M 8.51 M 8.51 M 4.62 M 4.62 M 4.62 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-418 M -411 M -394 M -366 M -343 M - -282 M -240 M -209 M -183 M -160 M -139 M -139 M -139 M -139 M -72.8 M -72.8 M -72.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

20 M 25 M 83.3 M 107 M 125 M - 182 M 214 M 207 M 224 M 126 M 140 M 140 M 140 M 140 M 38.5 M 38.5 M 38.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

18.1 M 22.5 M 41.8 M 61.1 M 76 M 95.8 M 126 M 160 M 152 M 159 M 26.2 M 5.84 M 5.84 M 5.84 M 5.84 M 12.7 M 12.7 M 12.7 M - 20.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

16.2 M 20.6 M 36.1 M 60.8 M 78.4 M - 128 M 164 M 188 M 208 M 114 M 132 M 132 M 132 M 132 M 33.9 M 33.9 M 33.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

16.2 M 20.6 M 36.1 M 60.8 M 78.4 M 97.8 M 128 M 164 M 188 M 208 M 114 M 132 M 132 M 132 M 132 M -71.7 M -71.7 M -71.7 M -49.1 M -44.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency